It has been reported that a low level of METTL3 increases the sensitivity of cancer cells to the treatment of DNA damage, while upregulated METTL3 reduces the survival rate of patients with head and neck squamous cell carcinoma who have received cisplatin or radiation treatment of DNA damage (126). The gene discussed is METTL3; the disease is head and neck squamous cell carcinoma.